Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Influenza

Free Subscription Articles published in PLoS Med Retrieve available abstracts of 55 articles: HTML format

Single Articles

September 2025
1. LEWIS BR, Hendrick J, Byrne K, Odette M, et al
   Psilocybin-assisted group psychotherapy and mindfulness-based stress reduction for frontline healthcare provider COVID-19-related depression and burnout: A randomized controlled trial.
   PLoS Med. 2025;22:e1004519.
   PubMed     Abstract available
   
   
   
2. PREISS A, Bhatia A, Aragon LV, Baratta JM, et al
   Effect of Paxlovid treatment during acute COVID-19 on Long COVID onset: An EHR-based target trial emulation from the N3C and RECOVER consortia.
   PLoS Med. 2025;22:e1004711.
   PubMed     Abstract available
   
   
   July 2025
3. KNOWLTON KU, Siegel LK, Barkauskas CE, Bhagani S, et al
   Passive immunotherapy for adults hospitalized with COVID-19: An individual participant data meta-analysis of six randomized controlled trials.
   PLoS Med. 2025;22:e1004616.
   PubMed     Abstract available
   
   
   June 2025
4. GOODFELLOW L, Procter SR, Koltai M, Waterlow NR, et al
   The potential global health impact and cost-effectiveness of next-generation influenza vaccines: A modelling analysis.
   PLoS Med. 2025;22:e1004655.
   PubMed     Abstract available
   
   
   March 2025
5. AHMADI-ABHARI S, Bandosz P, Shipley MJ, Lindbohm JV, et al
   Direct and indirect impacts of the COVID-19 pandemic on life expectancy and person-years of life lost with and without disability: A systematic analysis for 18 European countries, 2020-2022.
   PLoS Med. 2025;22:e1004541.
   PubMed     Abstract available
   
   
   February 2025
6. RAZIEH C, Powell B, Drummond R, Ward IL, et al
   Understanding the quality of ethnicity data recorded in health-related administrative data sources compared with Census 2021 in England.
   PLoS Med. 2025;22:e1004507.
   PubMed     Abstract available
   
   
   January 2025
7. BHATIA A, Preiss AJ, Xiao X, Brannock MD, et al
   Effect of nirmatrelvir/ritonavir (Paxlovid) on hospitalization among adults with COVID-19: An electronic health record-based target trial emulation from N3C.
   PLoS Med. 2025;22:e1004493.
   PubMed     Abstract available
   
   
   
8. PETER RS, Nieters A, Gopel S, Merle U, et al
   Persistent symptoms and clinical findings in adults with post-acute sequelae of COVID-19/post-COVID-19 syndrome in the second year after acute infection: A population-based, nested case-control study.
   PLoS Med. 2025;22:e1004511.
   PubMed     Abstract available
   
   
   
9. ODD D, Stoianova S, Williams T, Fleming P, et al
   Child mortality in England after national lockdowns for COVID-19: An analysis of childhood deaths, 2019-2023.
   PLoS Med. 2025;22:e1004417.
   PubMed     Abstract available
   
   
   
10. RAGONNET R, Hughes AE, Shipman DS, Meehan MT, et al
    Estimating the impact of school closures on the COVID-19 dynamics in 74 countries: A modelling analysis.
    PLoS Med. 2025;22:e1004512.
    PubMed     Abstract available
    
    
    November 2024
11. HO FK, Dale C, Mizani MA, Bolton T, et al
    Routine measurement of cardiometabolic disease risk factors in primary care in England before, during, and after the COVID-19 pandemic: A population-based cohort study.
    PLoS Med. 2024;21:e1004485.
    PubMed     Abstract available
    
    
    September 2024
12. INIZAN C, Courtot A, Sturmach C, Griffon AF, et al
    Levels and functionality of Pacific Islanders' hybrid humoral immune response to BNT162b2 vaccination and delta/omicron infection: A cohort study in New Caledonia.
    PLoS Med. 2024;21:e1004397.
    PubMed     Abstract available
    
    
    
13. SCHILLING WHK, Mukaka M, Callery JJ, Llewelyn MJ, et al
    Evaluation of hydroxychloroquine or chloroquine for the prevention of COVID-19 (COPCOV): A double-blind, randomised, placebo-controlled trial.
    PLoS Med. 2024;21:e1004428.
    PubMed     Abstract available
    
    
    July 2024
14. BONNET G, Bimba J, Chavula C, Chifamba HN, et al
    Cost-effectiveness of COVID rapid diagnostic tests for patients with severe/critical illness in low- and middle-income countries: A modeling study.
    PLoS Med. 2024;21:e1004429.
    PubMed     Abstract available
    
    
    
15. FORMANEK T, Potocar L, Wolfova K, Melicharova H, et al
    Deaths with COVID-19 and from all-causes following first-ever SARS-CoV-2 infection in individuals with preexisting mental disorders: A national cohort study from Czechia.
    PLoS Med. 2024;21:e1004422.
    PubMed     Abstract available
    
    
    June 2024
16. SAMUEL M, Park RY, Eastwood SV, Eto F, et al
    Trends in weight gain recorded in English primary care before and during the Coronavirus-19 pandemic: An observational cohort study using the OpenSAFELY platform.
    PLoS Med. 2024;21:e1004398.
    PubMed     Abstract available
    
    
    May 2024
17. EUVRARD J, Timmerman V, Keene CM, Phelanyane F, et al
    The cyclical cascade of HIV care: Temporal care engagement trends within a population-wide cohort.
    PLoS Med. 2024;21:e1004407.
    PubMed     Abstract available
    
    
    April 2024
18. JUNG SM, Loo SL, Howerton E, Contamin L, et al
    Potential impact of annual vaccination with reformulated COVID-19 vaccines: Lessons from the US COVID-19 scenario modeling hub.
    PLoS Med. 2024;21:e1004387.
    PubMed     Abstract available
    
    
    
19. ELIGULASHVILI A, Gordon M, Lee JS, Lee J, et al
    Long-term outcomes of hospitalized patients with SARS-CoV-2/COVID-19 with and without neurological involvement: 3-year follow-up assessment.
    PLoS Med. 2024;21:e1004263.
    PubMed     Abstract available
    
    
    February 2024
20. NICKEL NC, Phillips-Beck W, Enns JE, Ekuma O, et al
    COVID-19 diagnostic testing and vaccinations among First Nations in Manitoba: A nations-based retrospective cohort study using linked administrative data, 2020-2021.
    PLoS Med. 2024;21:e1004348.
    PubMed     Abstract available
    
    
    
21. MKOMA GF, Agyemang C, Benfield T, Rostila M, et al
    Risk of long COVID and associated symptoms after acute SARS-COV-2 infection in ethnic minorities: A nationwide register-linked cohort study in Denmark.
    PLoS Med. 2024;21:e1004280.
    PubMed     Abstract available
    
    
    January 2024
22. GHARPURE R, Chard AN, Cabrera Escobar M, Zhou W, et al
    Costs and cost-effectiveness of influenza illness and vaccination in low- and middle-income countries: A systematic review from 2012 to 2022.
    PLoS Med. 2024;21:e1004333.
    PubMed     Abstract available
    
    
    
23. PANAGI L, White SR, Pinto Pereira SM, Nugawela MD, et al
    Mental health in the COVID-19 pandemic: A longitudinal analysis of the CLoCk cohort study.
    PLoS Med. 2024;21:e1004315.
    PubMed     Abstract available
    
    
    December 2023
24. LEBLANC J, Dusserre-Telmon L, Chauvin A, Simon T, et al
    Intensified screening for SARS-CoV-2 in 18 emergency departments in the Paris metropolitan area, France (DEPIST-COVID): A cluster-randomized, two-period, crossover trial.
    PLoS Med. 2023;20:e1004317.
    PubMed     Abstract available
    
    
    November 2023
25. HOGAN AB, Wu SL, Toor J, Olivera Mesa D, et al
    Long-term vaccination strategies to mitigate the impact of SARS-CoV-2 transmission: A modelling study.
    PLoS Med. 2023;20:e1004195.
    PubMed     Abstract available
    
    
    
26. CARTULIARES MB, Rosenvinge FS, Mogensen CB, Skovsted TA, et al
    Evaluation of point-of-care multiplex polymerase chain reaction in guiding antibiotic treatment of patients acutely admitted with suspected community-acquired pneumonia in Denmark: A multicentre randomised controlled trial.
    PLoS Med. 2023;20:e1004314.
    PubMed     Abstract available
    
    
    September 2023
27. WATKINSON RE, Williams R, Gillibrand S, Munford L, et al
    Evaluating socioeconomic inequalities in influenza vaccine uptake during the COVID-19 pandemic: A cohort study in Greater Manchester, England.
    PLoS Med. 2023;20:e1004289.
    PubMed     Abstract available
    
    
    
28. KUCHARSKI AJ, Chung K, Aubry M, Teiti I, et al
    Real-time surveillance of international SARS-CoV-2 prevalence using systematic traveller arrival screening: An observational study.
    PLoS Med. 2023;20:e1004283.
    PubMed     Abstract available
    
    
    July 2023
29. XIONG X, Lui DTW, Chung MSH, Au ICH, et al
    Incidence of diabetes following COVID-19 vaccination and SARS-CoV-2 infection in Hong Kong: A population-based cohort study.
    PLoS Med. 2023;20:e1004274.
    PubMed     Abstract available
    
    
    
30. HILLARY RF, McCartney DL, Smith HM, Bernabeu E, et al
    Blood-based epigenome-wide analyses of 19 common disease states: A longitudinal, population-based linked cohort study of 18,413 Scottish individuals.
    PLoS Med. 2023;20:e1004247.
    PubMed     Abstract available
    
    
    
31. ANTILLON M, Li X, Willem L, Bilcke J, et al
    The age profile of respiratory syncytial virus burden in preschool children of low- and middle-income countries: A semi-parametric, meta-regression approach.
    PLoS Med. 2023;20:e1004250.
    PubMed     Abstract available
    
    
    June 2023
32. STOWE J, Miller E, Andrews N, Whitaker HJ, et al
    Risk of myocarditis and pericarditis after a COVID-19 mRNA vaccine booster and after COVID-19 in those with and without prior SARS-CoV-2 infection: A self-controlled case series analysis in England.
    PLoS Med. 2023;20:e1004245.
    PubMed     Abstract available
    
    
    
33. SMITH DRM, Shirreff G, Temime L, Opatowski L, et al
    Collateral impacts of pandemic COVID-19 drive the nosocomial spread of antibiotic resistance: A modelling study.
    PLoS Med. 2023;20:e1004240.
    PubMed     Abstract available
    
    
    
34. QIN K, Honjo K, Sherrill-Mix S, Liu W, et al
    Exposure of progressive immune dysfunction by SARS-CoV-2 mRNA vaccination in patients with chronic lymphocytic leukemia: A prospective cohort study.
    PLoS Med. 2023;20:e1004157.
    PubMed     Abstract available
    
    
    
35. MARINCOWITZ C, Bouamra O, Coats T, Surendra Kumar D, et al
    Major trauma presentations and patient outcomes in English hospitals during the COVID-19 pandemic: An observational cohort study.
    PLoS Med. 2023;20:e1004243.
    PubMed     Abstract available
    
    
    May 2023
36. MARTINSON NA, Nonyane BAS, Genade LP, Berhanu RH, et al
    Evaluating systematic targeted universal testing for tuberculosis in primary care clinics of South Africa: A cluster-randomized trial (The TUTT Trial).
    PLoS Med. 2023;20:e1004237.
    PubMed     Abstract available
    
    
    
37. BANHOLZER N, Zurcher K, Jent P, Bittel P, et al
    SARS-CoV-2 transmission with and without mask wearing or air cleaners in schools in Switzerland: A modeling study of epidemiological, environmental, and molecular data.
    PLoS Med. 2023;20:e1004226.
    PubMed     Abstract available
    
    
    April 2023
38. MORENO-AGOSTINO D, Fisher HL, Goodman A, Hatch SL, et al
    Long-term psychological distress trajectories and the COVID-19 pandemic in three British birth cohorts: A multi-cohort study.
    PLoS Med. 2023;20:e1004145.
    PubMed     Abstract available
    
    
    
39. SAXENA S, Chwa C
    Mental disorders and COVID-19 deaths: Clinical, public health, and human rights implications.
    PLoS Med. 2023;20:e1004220.
    PubMed     Abstract available
    
    
    
40. VIOLATO M, Pollard J, Lloyd A, Roope LSJ, et al
    The COVID-19 pandemic and health-related quality of life across 13 high- and low-middle-income countries: A cross-sectional analysis.
    PLoS Med. 2023;20:e1004146.
    PubMed     Abstract available
    
    
    
41. TOMLINSON M, Marlow M
    COVID-19 and mental health: Building back better or reimagining a new way forward?
    PLoS Med. 2023;20:e1004216.
    PubMed     Abstract available
    
    
    
42. AKSUNGER N, Vernot C, Littman R, Voors M, et al
    COVID-19 and mental health in 8 low- and middle-income countries: A prospective cohort study.
    PLoS Med. 2023;20:e1004081.
    PubMed     Abstract available
    
    
    
43. PINTO DA COSTA M, Stewart R
    Investigating time-dependent COVID-19 pandemic mental health data: Challenges and opportunities of using panel data analysis.
    PLoS Med. 2023;20:e1004219.
    PubMed     Abstract available
    
    
    
44. MYRAN DT, Roberts R, McArthur E, Jeyakumar N, et al
    Mental health and addiction health service use by physicians compared to non-physicians before and during the COVID-19 pandemic: A population-based cohort study in Ontario, Canada.
    PLoS Med. 2023;20:e1004187.
    PubMed     Abstract available
    
    
    
45. BU F, Steptoe A, Fancourt D
    Depressive and anxiety symptoms in adults during the COVID-19 pandemic in England: A panel data analysis over 2 years.
    PLoS Med. 2023;20:e1004144.
    PubMed     Abstract available
    
    
    
46. WITTEVEEN AB, Young SY, Cuijpers P, Ayuso-Mateos JL, et al
    COVID-19 and common mental health symptoms in the early phase of the pandemic: An umbrella review of the evidence.
    PLoS Med. 2023;20:e1004206.
    PubMed     Abstract available
    
    
    
47. BEACH B, Steptoe A, Zaninotto P
    Depression and anxiety in people with cognitive impairment and dementia during the COVID-19 pandemic: Analysis of the English Longitudinal Study of Ageing.
    PLoS Med. 2023;20:e1004162.
    PubMed     Abstract available
    
    
    
48. PATEL V, Fancourt D, Furukawa TA, Kola L, et al
    Reimagining the journey to recovery: The COVID-19 pandemic and global mental health.
    PLoS Med. 2023;20:e1004224.
    PubMed     Abstract available
    
    
    
49. WELS J, Wielgoszewska B, Moltrecht B, Booth C, et al
    Home working and social and mental wellbeing at different stages of the COVID-19 pandemic in the UK: Evidence from 7 longitudinal population surveys.
    PLoS Med. 2023;20:e1004214.
    PubMed     Abstract available
    
    
    
50. FUNG KW, Baye F, Baik SH, Zheng Z, et al
    Prevalence and characteristics of long COVID in elderly patients: An observational cohort study of over 2 million adults in the US.
    PLoS Med. 2023;20:e1004194.
    PubMed     Abstract available
    
    
    
51. ROCKERS PC, Leppanen JM, Tarullo A, Coetzee L, et al
    Evaluation of a community health worker home visit intervention to improve child development in South Africa: A cluster-randomized controlled trial.
    PLoS Med. 2023;20:e1004222.
    PubMed     Abstract available
    
    
    February 2023
52. NORDSTROM P, Ballin M, Nordstrom A
    Safety and effectiveness of monovalent COVID-19 mRNA vaccination and risk factors for hospitalisation caused by the omicron variant in 0.8 million adolescents: A nationwide cohort study in Sweden.
    PLoS Med. 2023;20:e1004127.
    PubMed     Abstract available
    
    
    
53. DAVISSE-PATURET C, Orri M, Legleye S, Florence AM, et al
    Suicidal ideation following self-reported COVID-19-like symptoms or serology-confirmed SARS-CoV-2 infection in France: A propensity score weighted analysis from a cohort study.
    PLoS Med. 2023;20:e1004171.
    PubMed     Abstract available
    
    
    
54. GYLLENBERG D, Bastola K, Wan Mohd Yunus WMA, Mishina K, et al
    Comparison of new psychiatric diagnoses among Finnish children and adolescents before and during the COVID-19 pandemic: A nationwide register-based study.
    PLoS Med. 2023;20:e1004072.
    PubMed     Abstract available
    
    
    
55. SCHWARZINGER M, Luchini S, Teschl M, Alla F, et al
    Mental disorders, COVID-19-related life-saving measures and mortality in France: A nationwide cohort study.
    PLoS Med. 2023;20:e1004134.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Influenza is free of charge.